It can be hypothesized that PD-1/PD-L1 signaling plays a significant role during myocardial injury, so patients affected by myocardial infarction and receiving ICIs might be at risk for adverse outcomes [57]. This evidence concerns the gene PDCD1 and myocardial infarction.